CAC-1000 CAC-1000

Dose: 5 to 15 ml
Single Dose: 10 (10)
Frequency: 8 hourly
Route: PO
Instructions: For hypoparathyroidism

Calcium Glubionate also known as Calcium Gluconate Lactobionate Monohydrate. . It is of Synthetic origin and belongs to Calcium salt. . The Molecular Weight of Calcium Glubionate is 610.50.

Calcium Glubionate is contraindicated in conditions like Hypercalcaemia,Renal calculi.

The severe or irreversible adverse effects of Calcium Glubionate, which give rise to further complications include Cardiac arrhythmias, Renal calculi, Sinus bradycardia.Calcium Glubionate produces potentially life-threatening effects which include Coma, Cardiac Arrest. which are responsible for the discontinuation of Calcium Glubionate therapy.The signs and symptoms that are produced after the acute overdosage of Calcium Glubionate include Hypercalcemia.The symptomatic adverse reactions produced by Calcium Glubionate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Vomiting, Anorexia, Constipation, Abdominal pain, Syncope, GI irritation, Mental disturbances.

Calcium Glubionate is primarily indicated in conditions like Cardiopulmonary resuscitation, Hypocalcaemia, Osteoporosis prophylaxis, and can also be given in adjunctive therapy as an alternative drug of choice in Severe hyperkalaemia, Severe hypermagnesaemia.

No data regarding the interactions of Calcium Glubionate was found.

Drug should not be given to Pregnant Mothers, patients suffering from Kidney dysfunction, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Syrups Store in a well closed container, at room temperature, . Protect from Sunlight, Moisture and Heat.

Solution of calcium salts are irritant and care should be taken to prevent extravasation during intravenous injection. Calcium glubionate should be used with caution in patients with impaired renal function, pre-existing cardiac arrhythmias, diarrhoea, malabsorption or diseases associated with elevated vitamin D concentrations such as sarcoidosis. Generally calcium salts should be avoided in patients with calcium renal calculi. Plasma-calcium concentrations should be monitored closely in patients with renal insufficiency and during parentral administration and if large doses of vitamin D are used.